leadf
logo-loader
viewCallitas Health Inc

Callitas Health successfully closes capital raise

The Cincinnati-based health and wellness company will use the proceeds as general working capital

Dollars
Callitas' strategy focuses on getting quick revenues from mass-appeal over-the-counter products and a more long-term blockbuster pipeline

Callitas Health Inc (CSE:LILY) (OTCQB:MPHMF) announced Thursday that it completed a non-brokered private placement to raise US$289,225.  

The Cincinnati-based health and wellness company’s stock rocketed nearly 35% on the OTC Markets Thursday to $0.093.

The company issued 3,856,333 units at a price of $0.075 per unit. Each unit consists of one share and one two-year warrant to purchase an additional share at $0.10.

The proceeds from the offering will be used for general working capital, the company said in a statement.

Callitas has a nimble strategy focused on getting quick revenues from mass-appeal over-the-counter products and a more long-term blockbuster pipeline.

Contact Uttara Choudhury at uttara@proactiveinvestors.com

Follow her on Twitter@UttaraProactive 

Quick facts: Callitas Health Inc

Price: - CAD

CSE:LILY
Market: CSE
Market Cap: -
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE

Canntab Therapeutics achieves major milestone receiving first U.S. patent...

Canntab Therapeutics (CSE: PILL-OTCQB: CTABF) CEO Larry Latowsky joined Steve Darling from Proactive Vancouver with news the company has secured protection for their intellectual property receiving a U.S. patent for “Modified Release Multi-Layer Tablet Cannabinoid Formulations.” Latowsky...

2 hours, 35 minutes ago

2 min read